课题基金 / 基金详情

I-Corps: Hybrid Halos for Biological Markers, Probes and Therapies

I-Corps: Hybrid Halos for Biological Markers, Probes and Therapies
I-Corps:生物标记、探针和治疗的混合光环
批准号:
1839049
负责人:
Ming Tang
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-15 至 2019-06-30

项目摘要

项目成果

Ming Tang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The broad impact/commercial potential of this I-Corps project is the introduction of a novel class of nanoparticle-molecular hybrid materials with a wide range of applications in the life sciences. These hybrid probes will enable the non-invasive delivery of ultra-violet and visible photons deep in tissue where the light could not otherwise penetrate, to mark targets for therapy or diagnostics. For example, this light may be used to trigger the uncaging of tumor drugs at local points of interest, excite fluorophores for imaging, initiate neural firing or cellular signal transduction cascades in genetically engineered species, etc. The application of our materials will enable more advanced experiments, leading to better understanding of complex systems such as the brain, which will ultimately help treat and prevent brain disorders. In addition, since these particles perform photon upconversion at very low excitation densities, much cheaper non-coherent light sources such as red LEDs can replace the high power near-infrared lasers currently required today. This is ideal for point of care testing for personalized medicine and the battlefield where instant diagnosis and portability are essential. The I-Corps project is based on a molecular-nanocrystal hybrid that upconverts light via a multi-step energy transfer process. For the life science applications mentioned above, our label exhibits much higher sensitivity than existing commercial technologies by avoiding excitation at the optical window where biological species absorb, scatter, and autofluoresce. Different components of the system can be tuned to selectively produce high energy ultra-violet and visible photons from incoming low energy near-infrared photons. Synthetic control of both the nanocrystal light absorber and molecular transmitter and emitter have resulted in a high photon upconversion quantum yield. Fundamental understanding and further development of this technology involves interdisciplinary research in the fields of photophysics, material science, and synthetic chemistry.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IRES Track 1: Self-assembled liquids and thin films for efficient photon upconversion with triplet excitons in air
  • 批准号:
    2142762
  • 项目类别:
    Standard Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    Ming Tang
  • 依托单位:
Plasmon-induced Triplet Energy Transfer (PITET) for Photon Upconversion
  • 批准号:
    2147792
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2021
  • 负责人:
    Ming Tang
  • 依托单位:
PFI-TT: Achieving efficient production of visible light from semiconductor nanocrystals in water
  • 批准号:
    2147791
  • 项目类别:
    Standard Grant
  • 资助金额:
    $25.0万
  • 财政年份:
    2021
  • 负责人:
    Ming Tang
  • 依托单位:
Plasmon-induced Triplet Energy Transfer (PITET) for Photon Upconversion
  • 批准号:
    2003544
  • 项目类别:
    Standard Grant
  • 资助金额:
    $45.0万
  • 财政年份:
    2020
  • 负责人:
    Ming Tang
  • 依托单位:
国内基金
海外基金
一种经心房覆膜血管支架植入 Hybrid Fontan 手术的 临床新技术研究
基于深度压缩技术的Hybrid像素探测器读出系统原型机研制
  • 批准号:
    11875146
  • 项目类别:
    面上项目
  • 资助金额:
    62.0万元
  • 批准年份:
    2018
  • 负责人:
    王东
  • 依托单位:
模拟胰岛“hybrid”修饰抗原诱导tolDC免疫保护1型糖尿病β细胞研究
  • 批准号:
    81770777
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2017
  • 负责人:
    顾愹
  • 依托单位:
PSMA靶向Hybrid-SiO2基纳米诊疗剂用于前列腺癌HIFU治疗及增效机制研究
  • 批准号:
    81601499
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    17.0万元
  • 批准年份:
    2016
  • 负责人:
    姚明华
  • 依托单位: